JH
Jeffrey Hymes
Also known as: Dr. Jeff Hymes, Dr. Jeffrey Hymes
Fresenius Medical Care, American College of Physicians, Boston University Medical Center, Yale-New Haven Hospital, Fresenius Kidney Care, Albert Einstein College of Medicine
About
Dr. Hymes is EVP, Global Head of Clinical Affairs for Fresenius Medical Care; CMO for Fresenius Kidney Care; and Chairman, Pharmacy & Therapeutics Committee. A graduate of Yale College and the Albert Einstein School of Medicine, board certified in internal medicine, nephrology and critical care.
Employment
-
Fresenius Medical Care EVP, Global Head of Clinical Affairs and CMO, Fresenius Kidney Care2020 - Present
-
Fresenius Kidney Care Sr. VP, CMO, Chair, Pharmacy & Therapeutics Commitee2012 - 2020
-
Fresenius Medical Care North America Associate CMO, Chair, Pharmacy & Therapeutics Committee2007 - 2011
-
American College of Physicians Member2003 - Present
Education
-
Boston University Medical Center Research Fellow in Nephrology1981 - 1983
-
Boston University Medical Center Fellow in Clinical Nephrology1980 - 1981
-
Yale-New Haven Hospital Asst. Resident1978 - 1980
-
Yale-New Haven Hospital Intern1977 - 1978
-
Albert Einstein College of Medicine M.D.1973 - 1977
-
Yale University B.A.1970 - 1974
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension Save
- Management of Patients with Multidrug-Resistant Organisms in Outpatient Dialysis Facilities Save
- Prediction of Gastrointestinal Bleeding Hospitalization in Hemodialysis Save
- What We Learned from Ebola: Preparing Dialysis Units for the Next Outbreak. Save
- Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap. Save
- Incident diabetic foot ulcers and mortality in hemodialysis patients. Save
- A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. Save
- Introduction: Role of the medical director series. Save
- Anaphylaxis and hypotension after administration of peginesatide. Save
- Associates of cardiopulmonary arrest in the perihemodialytic period. Save